Outlook Therapeutics Inc (NASDAQ:OTLK)

2.18
Delayed Data
As of Oct 22
 +0.07 / +3.32%
Today’s Change
0.72
Today|||52-Week Range
4.26
+67.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Operating ActivitiesNet Income / Starting Line-8.4M-12.2M-9.7M-10.2M
 
 
 
 
 
Depreciation822.1K824.4K823.1K816.5K
 
 
 
 
 
Total Other Cash Flow529.0K3.6M2.0M2.8M
 
 
 
 
 
Funds From Operations-7.1M-7.7M-6.9M-6.7M
 
 
 
 
 
Funds From/For Other Operating Expenses1.5M648.5K2.9M-414.9K
 
 
 
 
 
Net Cash Flow - Operating Activities-8.5M-8.4M-9.8M-6.3M
 
 
 
 
 
 
InvestingCapital Expenditures-168.0K-1.3M-236.4K-50.1K
 
 
 
 
 
Net Cash Flow Investing-168.0K-1.3M-236.4K-50.1K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-292.2K-261.3K-3.4M-1.7M
 
 
 
 
 
Net Proceeds Stock Sale14.9M928.2K11.9M7.9M
 
 
 
 
 
Common Preferred Redeemed0.00-1.1M0.000.00
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing14.6M-422.3K8.5M6.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----22.3K-5.7K
 
 
 
 
Net Change In Cash5.9M-10.1M-1.5M-66.6K